SkinBioTherapeutics (GB:SBTX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
SkinBioTherapeutics plc has announced the posting of its Annual Report and AGM notice to shareholders, with the AGM set for December 27, 2024. The company, specializing in skin health, is expanding its reach through strategic acquisitions and partnerships, focusing on cosmetic skincare and immune-modulating supplements. Investors can access the documents online for detailed insights into the company’s performance and future plans.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
